We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Seeks Input on Pediatric Trial Plans for Two Childhood Cancers
EMA Seeks Input on Pediatric Trial Plans for Two Childhood Cancers
March 11, 2013
The European Medicines Agency is seeking feedback on standard pediatric investigation plans (PIP) for two specific types of cancer with unmet medical needs in children, acute myeloid leukemia (AML) and rhabdomyosarcoma (RHAB).
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor